PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23053727-0	2013	Neferine inhibits the upregulation of CCL5 and CCR5 in vascular endothelial cells during chronic high glucose treatment.	neferine	0-8	C-C motif chemokine receptor 5	Homo sapiens	47-51	
23053727-8	2013	The increased level of ROS and elevated expressions of CCL5 and CCR5 at high glucose were significantly inhibited by neferine; meanwhile the decreased NO production upon chronic high glucose treatment was relieved.	neferine	117-125	C-C motif chemokine receptor 5	Homo sapiens	64-68	
23053727-10	2013	These data indicate that neferine can reduce the upregulation of CCL5 and CCR5 of vascular endothelium exposure to chronic high glucose and prevent or inhibit subsequent occurrence of inflammation in blood vessels possibly through antioxidation.	neferine	25-33	C-C motif chemokine receptor 5	Homo sapiens	74-78